Is there really good news about pandemic diabetic nephropathy?
作者信息
Friedman Eli A, Friedman Amy L
出版信息
Nephrol Dial Transplant. 2007 Mar;22(3):681-3. doi: 10.1093/ndt/gfl735. Epub 2007 Jan 5.
Abstract
摘要
相似文献
1
Is there really good news about pandemic diabetic nephropathy?
Nephrol Dial Transplant. 2007 Mar;22(3):681-3. doi: 10.1093/ndt/gfl735. Epub 2007 Jan 5.
2
3
Clinical outcomes for patients with diabetic nephropathy.
EDTNA ERCA J. 1999 Jan-Mar;25(1):23-7. doi: 10.1111/j.1755-6686.1999.tb00008.x.
4
Diabetic nephropathy: a global and growing threat.
Hong Kong Med J. 2010 Aug;16(4):244-5.
5
Diabetic nephropathy in hemodialysis patients in Constantine, Algeria.
Saudi J Kidney Dis Transpl. 2015 Jan;26(1):139-40.
6
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE.
Nephrology (Carlton). 2020 Oct;25 Suppl 2:12-45. doi: 10.1111/nep.13785.
7
[Universalistic medicine in relation to diabetes as a chronic disease at the turn of 20th and 21st centuries].
Pol Merkur Lekarski. 2002 Nov;13(77):410-2.
8
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE - EXECUTIVE SUMMARY.
Nephrology (Carlton). 2020 Oct;25 Suppl 2:3-11. doi: 10.1111/nep.13763.
9
Allograft diabetic nephropathy may progress to end-stage renal disease.
Pediatr Transplant. 2004 Aug;8(4):351-6. doi: 10.1111/j.1399-3046.2004.00182.x.
10
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.
Am J Kidney Dis. 1999 Nov;34(5):795-808. doi: 10.1016/S0272-6386(99)70035-1.
引用本文的文献
1
A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat.
Prostaglandins Other Lipid Mediat. 2016 Sep;125:40-7. doi: 10.1016/j.prostaglandins.2016.07.003. Epub 2016 Jul 16.
2
Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats.
Life Sci. 2009 Aug 26;85(9-10):357-64. doi: 10.1016/j.lfs.2009.06.019. Epub 2009 Jul 23.
3
Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL.
Obesity (Silver Spring). 2009 Nov;17(11):1994-2002. doi: 10.1038/oby.2009.137. Epub 2009 May 7.
4
Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.
Endocrine. 2009 Aug;36(1):126-34. doi: 10.1007/s12020-009-9190-2. Epub 2009 Apr 23.
5
LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat.
Diabetologia. 2008 May;51(5):882-91. doi: 10.1007/s00125-008-0935-x. Epub 2008 Mar 4.
本文引用的文献
1
Influenza. New study casts doubt on plans for pandemic containment.
Science. 2006 Feb 24;311(5764):1084. doi: 10.1126/science.311.5764.1084.
2
Renoprotection of angiotensin receptor blockers: beyond blood pressure lowering.
Nephrol Dial Transplant. 2006 Apr;21(4):846-9. doi: 10.1093/ndt/gfl013. Epub 2006 Feb 13.
3
Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register.
J Intern Med. 2006 Mar;259(3):314-22. doi: 10.1111/j.1365-2796.2006.01617.x.
4
Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis.
Diabet Med. 2006 Feb;23(2):164-70. doi: 10.1111/j.1464-5491.2005.01751.x.
5
Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes.
Kidney Int. 2006 Jan;69(2):383-7. doi: 10.1038/sj.ki.5000061.
6
Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.
Kidney Int. 2006 Apr;69(8):1438-43. doi: 10.1038/sj.ki.5000097.
7
Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values.
Diabetes Care. 2005 Oct;28(10):2361-6. doi: 10.2337/diacare.28.10.2361.
8
Lifestyle modification and progressive renal failure.
Nephrology (Carlton). 2005 Aug;10(4):387-92. doi: 10.1111/j.1440-1797.2005.00439.x.
9
Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?
Kidney Int. 2005 May;67(5):1684-91. doi: 10.1111/j.1523-1755.2005.00265.x.
10
The evolving diabetes burden in the United States.
Ann Intern Med. 2004 Jun 1;140(11):945-50. doi: 10.7326/0003-4819-140-11-200406010-00035.
Zotero 插件